In mouse xenograft models of NSCLS, the transfection of anti‐B7‐H3 CAR into NK‐92MI cells resulted in a notable increase in the ability of NK‐92MI cells to destroy B7‐H3‐positive tumor cells. The gene discussed is CD276; the disease is neoplasm.